SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-19-001891
Filing Date
2019-06-13
Accepted
2019-06-13 17:12:01
Documents
3
Period of Report
2019-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm 8-K 24900
2 FIRST AMENDMENT TO SHARE PURCHASE AGREEMENT xenetic_8k-ex0201.htm EX-2.1 16185
3 FIRST AMENDMENT TO ASSIGNMENT AGREEMENT xenetic_8k-ex1001.htm EX-10.1 14545
  Complete submission text file 0001683168-19-001891.txt   56971
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 19896832
SIC: 2834 Pharmaceutical Preparations